Hofman, V.; Lassalle, S.; Bence, C.; Long-Mira, E.; Nahon-Estève, S.; Heeke, S.; Lespinet-Fabre, V.; Butori, C.; Ilié, M.; Hofman, P.
Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients? Cancers 2018, 10, 70.
https://doi.org/10.3390/cancers10030070
AMA Style
Hofman V, Lassalle S, Bence C, Long-Mira E, Nahon-Estève S, Heeke S, Lespinet-Fabre V, Butori C, Ilié M, Hofman P.
Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients? Cancers. 2018; 10(3):70.
https://doi.org/10.3390/cancers10030070
Chicago/Turabian Style
Hofman, Véronique, Sandra Lassalle, Coraline Bence, Elodie Long-Mira, Sacha Nahon-Estève, Simon Heeke, Virginie Lespinet-Fabre, Catherine Butori, Marius Ilié, and Paul Hofman.
2018. "Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?" Cancers 10, no. 3: 70.
https://doi.org/10.3390/cancers10030070
APA Style
Hofman, V., Lassalle, S., Bence, C., Long-Mira, E., Nahon-Estève, S., Heeke, S., Lespinet-Fabre, V., Butori, C., Ilié, M., & Hofman, P.
(2018). Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients? Cancers, 10(3), 70.
https://doi.org/10.3390/cancers10030070